Age-related macular degeneration in the aspect of chronic low-grade inflammation (pathophysiological parainflammation)

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Nita, Małgorzata ^a   Grzybowski, Andrzej ^b,c   Ascaso, Francisco J ^d,e   Huerva, Valentín ^f,g  

^a Domestic and Specialized Medicine Centre Dilmed   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^c Department of Ophthalmology   (Poland)

^d HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^e INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^f HOSPITAL ARNAU DE VILANOVA   (Spain)

^g UNIVERSITY OF LLEIDA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT; OXIDIZED LOW DENSITY LIPOPROTEIN; COMPLEMENT FACTOR H;

AGE RELATED MACULAR DEGENERATION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CHOROID; CHRONIC INFLAMMATION; CHRONIC LOW GRADE INFLAMMATION; COMPLEMENT SYSTEM; DNA POLYMORPHISM; DRUSEN; HUMAN; MACROPHAGE; MICROGLIA; RETINA; IMMUNOLOGY; INFLAMMATION; MACULAR DEGENERATION; METABOLISM; PATHOLOGY;

AUTOANTIBODIES; COMPLEMENT FACTOR H; HUMANS; INFLAMMATION; MACULAR DEGENERATION;

EID: 84907246793     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/930671     Document Type: Article

References (116)

1. de Jong P. T. V. M., Age-related macular degeneration. The New England Journal of Medicine 2006 355 14 1474 1485 10.1056/NEJMra062326 2-s2.0-33749440219
2. Friedman D., O'Colmain B., Munoz B., Prevalence of age-related macular degeneration in the United States. Archives of Ophthalmology 2004 122 564 572
3. Klein R., Peto T., Bird A., Vannewkirk M. R., The epidemiology of age-related macular degeneration. American Journal of Ophthalmology 2004 137 3 486 495 10.1016/j.ajo.2003.11.069 2-s2.0-1542297335
4. Bhutto I. A., McLeod D. S., Hasegawa T., Kim S. Y., Merges C., Tong P., Lutty G. A., Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Experimental Eye Research 2006 82 1 99 110 10.1016/j.exer.2005.05.007 2-s2.0-30344447284
5. Zarbin M. A., Current concepts in the pathogenesis of age-related macular degeneration. Archives of Ophthalmology 2004 122 4 598 614 10.1001/archopht.122.4.598 2-s2.0-1842478123
6. Fine S. L., Berger J. W., Maguire M. G., Ho A. C., Age-related macular degeneration. New England Journal of Medicine 2000 342 7 483 492 10.1056/NEJM200002173420707 2-s2.0-0034677435
7. Bhutto I., Lutty G., Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Molecular Aspects of Medicine 2012 33 4 295 317 10.1016/j.mam.2012.04.005 2-s2.0-84863727273
8. Parmeggiani F., Romano M. R., Costagliola C., Semeraro F., Incorvaia C., D'Angelo S., Perri P., De Palma P., De Nadai K., Sebastiani A., Mechanism of inflammation in age-related macular degeneration. Mediators of Inflammation 2012 2012 16 546786 10.1155/2012/546786 2-s2.0-84870216842
9. Xu H., Chen M., Forrester J. V., Para-inflammation in the aging retina. Progress in Retinal and Eye Research 2009 28 5 348 368 10.1016/j.preteyeres.2009.06.001 2-s2.0-67651155742
10. Patel M., Chan C. C., Immunopathological aspects of age-related macular degeneration. Seminars in Immunopathology 2008 30 2 97 110 10.1007/s00281-008-0112-9 2-s2.0-42449105692
11. Rodrigues E. B., Inflammation in dry age-related macular degeneration. Ophthalmologica 2007 221 3 143 152 10.1159/000099293 2-s2.0-34247344069
12. Donoso L. A., Kim D., Frost A., Callahan A., Hageman G., The role of inflammation in the pathogenesis of age-related macular degeneration. Survey of Ophthalmology 2006 51 2 137 152 10.1016/j.survophthal.2005.12.001 2-s2.0-33144459399
13. Anderson D. H., Mullins R. F., Hageman G. S., Johnson L. V., A role for local inflammation in the formation of drusen in the aging eye. American Journal of Ophthalmology 2002 134 3 411 431 10.1016/S0002-9394(02)01624-0 2-s2.0-0036741098
14. Medzhitov R., Origin and physiological roles of inflammation. Nature 2008 454 7203 428 435 10.1038/nature07201 2-s2.0-47949099098
15. Jager R. D., Mieler W. F., Miller J. W., Age-related macular degeneration. The New England Journal of Medicine 2008 358 24 2606 2617 10.1056/NEJMra0801537 2-s2.0-45149098715
16. Forrester J. V., Lumsden L., Duncan L., Dick A. D., Choroidal dendritic require activation to present antigen and resident choroidal macrophages potentiate this response. The British Journal of Ophthalmology 2005 89 3 369 377 10.1136/bjo.2004.054197 2-s2.0-14744279701
17. Forrester J. V., Liversidge J., Dua H. S., Regulation of the local immune response by retinal cells. Current Eye Research 1990 9 183 191 2-s2.0-0025122841
18. Campa C., Costagliola C., Incorvaia C., Sheridan C., Semeraro F., de Nadai K., Sebastiani A., Parmeggiani F., Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications. Mediators of Inflammation 2010 2010 14 546826 10.1155/2010/546826 2-s2.0-77957899993
19. Wu J., Seregard S., Algvere P. V., Photochemical damage of the retina. Survey of Ophthalmology 2006 51 5 461 481 10.1016/j.survophthal.2006.06.009 2-s2.0-33748049785
20. Heck D. E., Vetrano A. M., Mariano T. M., Laskin J. D., UVB light stimulates production of reactive oxygen species: unexpected role for catalase. The Journal of Biological Chemistry 2003 278 25 22432 22436 10.1074/jbc.C300048200 2-s2.0-0038266168
21. Cai J., Nelson K. C., Wu M., Sternberg P. Jr., Sternberg P. J., Jones D. P., Oxidative damage and protection of the RPE. Progress in Retinal and Eye Research 2000 19 2 205 221 10.1016/S1350-9462(99)00009-9 2-s2.0-0033991466
22. Naik E., Dixit V. M., Mitochondrial reactive oxygen species drive proinflammatory cytokine production. The Journal of Experimental Medicine 2011 208 3 417 420 10.1084/jem.20110367 2-s2.0-79952712223
23. Wang H., Wittchen E. S., Hartnett M. E., Breaking barriers: insight into the pathogenesis of neovascular agerelated macular degeneration. Eye and Brain 2011 3 19 28
24. Li G., Osborne N. N., Oxidative-induced apoptosis to an immortalized ganglion cell line is caspase independent but involves the activation of poly(ADP-ribose)polymerase and apoptosis-inducing factor. Brain Research 2008 1188 1 35 43 10.1016/j.brainres.2007.10.073 2-s2.0-37349109987
25. Osborne N. N., Wood J. P. M., Metipranolol blunts nitric oxide-induced lipid peroxidation and death of retinal photoreceptors: a comparison with other anti-glaucoma drugs. Investigative Ophthalmology and Visual Science 2004 45 10 3787 3795 10.1167/iovs.04-0147 2-s2.0-4644316413
26. Ju W.-K., Chung I.-W., Kim K.-Y., Gwon J.-., Lee M.-., Oh S.-., Chun M.-., Sodium nitroprusside selectively induces apoptotic cell death in the outer retina of the rat. NeuroReport 2002 12 18 4075 4079 2-s2.0-0035930451
27. Crack P. J., Taylor J. M., Reactive oxygen species and the modulation of stroke. Free Radical Biology and Medicine 2005 38 11 1433 1444 10.1016/j.freeradbiomed.2005.01.019 2-s2.0-18844412788
28. Vohra R. S., Murphy J. E., Walker J. H., Ponnambalam S., Homer-Vanniasinkam S., Atherosclerosis and the lectin-like oxidized low-density lipoproteid scavenger receptor. Trends in Cardiovascular Medicine 2006 16 2 60 64 10.1016/j.tcm.2005.12.001 2-s2.0-32244436423
29. Duncan K. G., Bailey K. R., Kane J. P., Schwartz D. M., Human retinal pigment epithelial cells express scavenger receptors BI and BII. Biochemical and Biophysical Research Communications 2002 292 4 1017 1022 10.1006/bbrc.2002.6756 2-s2.0-0036290137
30. Xu H., Chen M., Manivannan A., Lois N., Forrester J. V., Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell 2008 7 1 58 68 10.1111/j.1474-9726.2007.00351.x 2-s2.0-38349116263
31. Yamagishi S., Adachi H., Takeuchi M., Enomoto M., Furuki K., Matsui T., Nakamura K., Imaizumi T., Serum level of advanced glycation end-products (AGEs) is an independent determinant of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic general population. Hormone and Metabolic Research 2007 39 11 845 848 10.1055/s-2007-991176 2-s2.0-36749040838
32. Lue L., Yan S. D., Stern D. M., Walker D. G., Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease. Current Drug Targets: CNS and Neurological Disorders 2005 4 3 249 266 10.2174/1568007054038210 2-s2.0-19944424142
33. Harja E., Bu D., Hudson B. I., Jong S. C., Shen X., Hallam K., Kalea A. Z., Lu Y., Rosario R. H., Oruganti S., Nikolla Z., Belov D., Lalla E., Ramasamy R., Shi F. Y., Schmidt A. M., Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. The Journal of Clinical Investigation 2008 118 1 183 194 10.1172/JCI32703 2-s2.0-38149078193
34. Gul A., Rahman M. A., Hasnain S. N., Role of fructose concentration on cataractogenesis in senile diabetic and non-diabetic patients. Graefe's Archive for Clinical and Experimental Ophthalmology 2009 247 6 809 814 10.1007/s00417-008-1027-9 2-s2.0-67349083565
35. Friedman E., The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. American Journal of Ophthalmology 2000 130 5 658 663 10.1016/S0002-9394(00)00643-7 2-s2.0-0033756108
36. McCarty C. A., Mukesh B. N., Fu C. L., Mitchell P., Taylor H. R., Risk factors for age-related maculopathy: the visual impairment project. Archives of Ophthalmology 2001 119 10 1455 1462 10.1001/archopht.119.10.1455 2-s2.0-0034800657
37. Crabb J. W., Miyagi M., Gu X., Shadrach K., West K. A., Sakaguchi H., Kamei M., Hasan A., Yan L., Rayborn M. E., Salomon R. G., Hollyfield J. G., Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 2002 99 23 14682 14687 10.1073/pnas.222551899 2-s2.0-11144258543
38. Handa J. T., Verzijl N., Matsunaga H., Aotaki-Keen A., Lutty G. A., Te Koppele J. M., Miyata T., Hjelmeland L. M., Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Investigative Ophthalmology and Visual Science 1999 40 3 775 779 2-s2.0-0033024626
39. Lin T., Walker G. B., Kurji K., Fang E., Law G., Prasad S. S., Kojic L., Cao S., White V., Cui J. Z., Matsubara J. A., Parainflammation associated with advanced glycation endproduct stimulation of RPE in vitro: implications for age-related degenerative diseases of the eye. Cytokine 2013 62 3 369 381 10.1016/j.cyto.2013.03.027 2-s2.0-84877804396
40. Ma W., Lee S., Guo J., Qu W., Hudson B. I., Schmidt A. M., Barile G. R., RAGE ligand upregulation of VEGF secretion in ARPE-19 cells. Investigative Ophthalmology and Visual Science 2007 48 3 1355 1361 10.1167/iovs.06-0738 2-s2.0-34047257846
41. Ohgami N., Nagai R., Ikemoto M., Arai H., Kuniyasu A., Horiuchi S., Nakayama H., CD36, a member of the class B scavenger receptor family, as a receptor for advanced glycation end products. The Journal of Biological Chemistry 2001 276 5 3195 3202 10.1074/jbc.M006545200 2-s2.0-0035793602
42. Booij J. C., Baas D. C., Beisekeeva J., Gorgels T. G. M. F., Bergen A. A. B., The dynamic nature of Bruch's membrane. Progress in Retinal and Eye Research 2010 29 1 1 18 10.1016/j.preteyeres.2009.08.003 2-s2.0-74749083052
43. Sarks S., Cherepanoff S., Killingsworth M., Sarks J., Relationship of basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Investigative Ophthalmology and Visual Science 2007 48 3 968 977 10.1167/iovs.06-0443 2-s2.0-34047244381
44. Curcio C. A., Presley J. B., Millican C. L., Medeiros N. E., Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. Experimental Eye Research 2005 80 6 761 775 10.1016/j.exer.2004.09.017 2-s2.0-20444430102
45. Sparrow J. R., Boulton M., RPE lipofuscin and its role in retinal pathobiology. Experimental Eye Research 2005 80 5 595 606 10.1016/j.exer.2005.01.007 2-s2.0-18044366931
46. Curcio C. A., Millican C. L., Basal linear deposit and large drusen are specific for early age-related maculopathy. Archives of Ophthalmology 1999 117 3 329 339 10.1001/archopht.117.3.329 2-s2.0-0344791691
47. Reale E., Groos S., Eckardt U., Eckardt C., Luciano L., New components of "basal laminar deposits" in age-related macular degeneration. Cells Tissues Organs 2009 190 3 170 181 10.1159/000187632 2-s2.0-68649113530
48. Ng K., Gugiu B., Renganathan K., Davies M. W., Gu X., Crabb J. S., Kim S. R., Rózanowska M. B., Bonilha V. L., Rayborn M. E., Salomon R. G., Sparrow J. R., Boulton M. E., Hollyfield J. G., Crabb J. W., Retinal pigment epithelium lipofuscin proteomics. Molecular and Cellular Proteomics 2008 7 7 1397 1405 10.1074/mcp.M700525-MCP200 2-s2.0-47849092882
49. Warburton S., Southwick K., Hardman R. M., Secrest A. M., Grow R. K., Xin H., Woolley A. T., Burton G. F., Thulin C. D., Examining the proteins of functional retinal lipofuscin using proteomic analysis as a guide for understanding its origin. Molecular Vision 2005 15 11 1122 1134 2-s2.0-29244435041
50. Augustin A. J., Kirchhof J., Inflammation and the pathogenesis of age-related macular degeneration. Expert Opinion on Therapeutic Targets 2009 13 6 641 651 10.1517/14728220902942322 2-s2.0-67649583541
51. Dastgheib K., Green W. R., Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Archives of Ophthalmology 1994 112 6 813 818 10.1001/archopht.1994.01090180111045 2-s2.0-0028361558
52. Kijlstra A., La Heij E. C., Hendrikse F., Immunological factors in the pathogenesis and treatment of age-related macular degeneration. Ocular Immunology and Inflammation 2005 13 1 3 11 10.1080/09273940590909185 2-s2.0-17844409078
53. Hageman G. S., Luthert P. J., Victor Chong N. H., Johnson L. V., Anderson D. H., Mullins R. F., An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Progress in Retinal and Eye Research 2001 20 6 705 732 10.1016/S1350-9462(01)00010-6 2-s2.0-0034832029
54. Johnson L. V., Ozaki S., Staples M. K., Erickson P. A., Anderson D. H., A potential role for immune complex pathogenesis in drusen formation. Experimental Eye Research 2000 70 4 441 449 10.1006/exer.1999.0798 2-s2.0-0033842370
55. Mullins R. F., Johnson L. V., Anderson D. H., Hageman G. S., Characterization of drusen-associated glycoconjugates. Ophthalmology 1997 104 2 288 294 10.1016/S0161-6420(97)30322-4 2-s2.0-0031019294
56. Mullins R. F., Russell S. R., Anderson D. H., Hageman G. S., Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB Journal 2000 14 7 835 846 2-s2.0-0034012166
57. Gu X., Meer S. G., Miyagi M., Rayborn M. E., Hollyfield J. G., Crabb J. W., Salomon R. G., Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. The Journal of Biological Chemistry 2003 278 43 42027 42035 10.1074/jbc.M305460200 2-s2.0-0142242222
58. Mullins R. F., Aptsiauri N., Hageman G. S., Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye 2001 15 3 390 395 10.1038/eye.2001.142 2-s2.0-0034954060
59. Bok D., Evidence for an inflammatory process in age-related macular degeneration gains new support. Proceedings of the National Academy of Sciences of the United States of America 2005 102 20 7053 7054 10.1073/pnas.0502819102 2-s2.0-18844453162
60. Nozaki M., Raisler B. J., Sakurai E., Sarma J. V., Barnum S. R., Lambris J. D., Chen Y., Zhang K., Ambati B. K., Baffi J. Z., Ambati J., Drusen complement components C3a and C5a promote choroidal neovascularization. Proceedings of the National Academy of Sciences of the United States of America 2006 103 7 2328 2333 10.1073/pnas.0408835103 2-s2.0-33144488589
61. Hageman G. S., Anderson D. H., Johnson L. V., Hancox L. S., Taiber A. J., Hardisty L. I., Hageman J. L., Stockman H. A., Borchardt J. D., Gehrs K. M., Smith R. J. H., Silvestri G., Russell S. R., Klaver C. C. W., Barbazetto I., Chang S., Yannuzzi L. A., Barile G. R., Merriam J. C., Smith R. T., Olsh A. K., Bergeron J., Zernant J., Merriam J. E., Gold B., Dean M., Allikmets R., A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 2005 102 20 7227 7232 10.1073/pnas.0501536102 2-s2.0-21044453724
62. Johnson L. V., Leitner W. P., Staples M. K., Anderson D. H., Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Experimental Eye Research 2001 73 6 887 896 10.1006/exer.2001.1094 2-s2.0-0035699547
63. Khandhadiaa S., Ciprianib V., Yatesb J. R. W., Loterya A. J., Age-related macular degeneration and the complement system. Immunobiology 2012 217 2 127 146 10.1016/j.imbio.2011.07.019
64. Zipfel P. F., Complement and immune defense: from innate immunity to human diseases. Immunology Letters 2009 126 1-2 1 7 10.1016/j.imlet.2009.07.005 2-s2.0-70249115440
65. Zipfel P. F., Heinen S., Józsi M., Skerka C., Complement and diseases: defective alternative pathway control results in kidney and eye diseases. Molecular Immunology 2006 43 1-2 97 106 10.1016/j.molimm.2005.06.015 2-s2.0-22544431912
66. Gasque P., Dean Y. D., McGreal E. P., Vanbeek J., Morgan B. P., Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 2000 49 1-2 171 186 10.1016/S0162-3109(00)80302-1 2-s2.0-0033921540
67. Despriet D. D. G., van Duijn C. M., Oostra B. A., Uitterlinden A. G., Hofman A., Wright A. F., ten Brink J. B., Bakker A., de Jong P. T. V. M., Vingerling J. R., Bergen A. A. B., Klaver C. C. W., Complement component C3 and risk of age-related macular degeneration. Ophthalmology 2009 116 3 474.e2 480.e2 10.1016/j.ophtha.2008.09.055 2-s2.0-61349122008
68. de Córdoba S. R., Esparza-Gordillo J., de Jorge E. G., Lopez-Trascasa M., Sánchez-Corral P., The human complement factor H: functional roles, genetic variations and disease associations. Molecular Immunology 2004 41 4 355 367 10.1016/j.molimm.2004.02.005 2-s2.0-2442433542
69. Zhou J., Jang Y. P., Kim S. R., Sparrow J. R., Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proceedings of the National Academy of Sciences of the United States of America 2006 103 44 16182 16187 10.1073/pnas.0604255103 2-s2.0-33750814597
70. Rohrer B., Long Q., Coughlin B., Brooks Wilson R., Huang Y., Qiao F., Tang P. H., Kunchithapautham K., Gilkeson G. S., Tomlinson S., A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Investigative Ophthalmology and Visual Science 2009 50 7 3056 3064 10.1167/iovs.08-2222 2-s2.0-67649989567
71. Rohrer B., Guo Y., Kunchithapautham K., Gilkeson G. S., Eliminating complement factor D reduces photoreceptor susceptibility to light-induced damage. Investigative Ophthalmology and Visual Science 2007 48 11 5282 5289 10.1167/iovs.07-0282 2-s2.0-38449085982
72. Bora N. S., Kaliappan S., Jha P., Xu Q., Sivasankar B., Harris C. L., Morgan B. P., Bora P. S., CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. The Journal of Immunology 2007 178 3 1783 1790 10.4049/jimmunol.178.3.1783 2-s2.0-33846507393
73. Bora P. S., Sohn J.-H., Cruz J. M. C., Jha P., Nishihori H., Wang Y., Kaliappan S., Kaplan H. J., Bora N. S., Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. The Journal of Immunology 2005 174 1 491 497 10.4049/jimmunol.174.1.491 2-s2.0-10844231850
74. Chen M., Forrester J. V., Xu H., Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. Experimental Eye Research 2007 84 4 635 645 10.1016/j.exer.2006.11.015 2-s2.0-33947160639
75. Weismann D., Hartvigsen K., Lauer N., Bennett K. L., Scholl H. P. N., Issa P. C., Cano M., Brandstätter H., Tsimikas S., Skerka C., Superti-Furga G., Handa J. T., Zipfel P. F., Witztum J. L., Binder C. J., Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 2011 478 7367 76 81 10.1038/nature10449 2-s2.0-80053904386
76. Edwards A. O., Ritter R. III, Abel K. J., Manning A., Panhuysen C., Farrer L. A., Complement factor H polymorphism and age-related macular degeneration. Science 2005 308 5720 421 424 10.1126/science.1110189 2-s2.0-17244379811
77. Haines J. L., Hauser M. A., Schmidt S., Scott W. K., Olson L. M., Gallins P., Spencer K. L., Shu Y. K., Noureddine M., Gilbert J. R., Schnetz-Boutaud N., Agarwal A., Postel E. A., Pericak-Vance M. A., Complement factor H variant increases the risk of age-related macular degeneration. Science 2005 308 5720 419 421 10.1126/science.1110359 2-s2.0-20244388812
78. Bhutto I. A., Baba T., Merges C., Juriasinghani V., McLeod D. S., Lutty G. A., C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration. The British Journal of Ophthalmology 2011 95 9 1323 1330 10.1136/bjo.2010.199216 2-s2.0-80052135068
79. Johnson P. T., Betts K. E., Radeke M. J., Hageman G. S., Anderson D. H., Johnson L. V., Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proceedings of the National Academy of Sciences of the United States of America 2006 103 46 17456 17461 10.1073/pnas.0606234103 2-s2.0-33751243644
80. Pepys M. B., Hirschfield G. M., C-reactive protein: a critical update. The Journal of Clinical Investigation 2003 111 12 1805 1812 10.1172/JCI200318921 2-s2.0-0042744797
81. Hong T., Tan A. G., Mitchell P., Wang J. J., A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration. Survey of Ophthalmology 2011 56 3 184 194 10.1016/j.survophthal.2010.08.007 2-s2.0-79954630189
82. Robman L., Baird P. N., Dimitrov P. N., Richardson A. J., Guymer R. H., C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progression. Ophthalmology 2010 117 10 1982 1988 10.1016/j.ophtha.2010.02.003 2-s2.0-77957591829
83. Seddon J. M., George S., Rosner B., Rifai N., Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Archives of Ophthalmology 2005 123 6 774 782 10.1001/archopht.123.6.774 2-s2.0-20644467790
84. Vine A. K., Stader J., Branham K., Musch D. C., Swaroop A., Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 2005 112 12 2076 2080 10.1016/j.ophtha.2005.07.004 2-s2.0-28344438168
85. Klein R., Klein B. E. K., Knudtson M. D., Wong T. Y., Shankar A., Tsai M. Y., Systemic markers of inflammation, endothelial dysfunction, and age-related maculopathy. American Journal of Ophthalmology 2005 140 1 35.e1 35.e12 10.1016/j.ajo.2005.01.051 2-s2.0-22444443854
86. McGwin G. Jr., Hall T. A., Xie A., Owsley C., The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study. British Journal of Ophthalmology 2005 89 9 1166 1170 10.1136/bjo.2005.067397 2-s2.0-24144464327
87. Józsi M., Zipfel P. F., Factor H family proteins and human diseases. Trends in Immunology 2008 29 8 380 387
88. Francis P. J., Klein M. L., Update on the role of genetics in the onset of age-related macular degeneration. Journal of Clinical Ophthalmology 2011 5 1 1127 1133 2-s2.0-80051710075
89. Gehrmann J., Matsumoto Y., Kreutzberg G. W., Microglia: intrinsic immuneffector cell of the brain. Brain Research Reviews 1995 20 3 269 287 10.1016/0165-0173(94)00015-H 2-s2.0-0029076362
90. Mrak R. E., Griffin W. S. T., Glia and their cytokines in progression of neurodegeneration. Neurobiology of Aging 2005 26 3 349 354 10.1016/j.neurobiolaging.2004.05.010 2-s2.0-11444256801
91. Xu H., Chen M., Mayer E. J., Forrester J. V., Dick A. D., Turnover of resident retinal microglia in the normal adult mouse. Glia 2007 55 11 1189 1198 10.1002/glia.20535 2-s2.0-34547645633
92. Gupta N., Brown K. E., Milam A. H., Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Experimental Eye Research 2003 76 4 463 471 10.1016/S0014-4835(02)00332-9 2-s2.0-0037375042
93. Patel M., Chan C., Immunopathological aspects of age-related macular degeneration. Seminars in Immunopathology 2008 30 2 97 110 10.1007/s00281-008-0112-9 2-s2.0-42449105692
94. Langmann T., Microglia activation in retinal degeneration. Journal of Leukocyte Biology 2007 81 6 1345 1351 10.1189/jlb.0207114 2-s2.0-34249744612
95. Penfold P. L., Madigan M. C., Gillies M. C., Provis J. M., Immunological and aetiological aspects of macular degeneration. Progress in Retinal and Eye Research 2001 20 3 385 414 10.1016/S1350-9462(00)00025-2 2-s2.0-0035077783
96. Morohoshi K., Patel N., Ohbayashi M., Chong V., Grossniklaus H. E., Bird A. C., Ono S. J., Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization. Experimental and Molecular Pathology 2012 92 1 64 73 10.1016/j.yexmp.2011.09.017 2-s2.0-81055139499
97. Sivaprasad S., Bailey T. A., Chong V. N. H., Bruch's membrane and the vascular intima: is there a common basis for age-related changes and disease? Clinical and Experimental Ophthalmology 2005 33 5 518 523 10.1111/j.1442-9071.2005.01074.x 2-s2.0-33644788693
98. Ravetch J. V., Bolland S., IgG Fc receptors. Annual Review of Immunology 2001 19 275 290 10.1146/annurev.immunol.19.1.275 2-s2.0-0035057022
99. Nimmerjahn F., Ravetch J. V., Fc γ receptors as regulators of immune responses. Nature Reviews Immunology 2008 8 1 34 47 10.1038/nri2206 2-s2.0-37549036732
100. Murinello S., Mullins R. F., Lotery A. J., Perry V. H., Teeling J. L., Complex inflammation in the mouse retina and early age-related macular degeneration. Investigative Ophthalmology and Visual Science 2014 55 247 258
101. Radi Z. A., Kehrli M. E. Jr., Ackermann M. R., Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration. Journal of Veterinary Internal Medicine 2001 15 6 516 529 10.1111/j.1939-1676.2001.tb01586.x 2-s2.0-0035514524
102. Mullins R. F., Skeie J. M., Malone E. A., Kuehn M. H., Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina. Molecular Vision 2006 12 224 235 2-s2.0-33645409461
103. Shankar A., Mitchell P., Rochtchina E., Tan J., Wang J. J., Association between circulating white blood cell count and long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. American Journal of Epidemiology 2007 165 4 375 382 10.1093/aje/kwk022 2-s2.0-33847006608
104. Blumenkranz M. S., Russell S. R., Robey M. G., Kott-Blumenkranz R., Penneys N., Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986 93 5 552 558 10.1016/S0161-6420(86)33702-3 2-s2.0-0022518375
105. Crowther M., Brown N. J., Bishop E. T., Lewis C. E., Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. Journal of Leukocyte Biology 2001 70 4 478 490 2-s2.0-0034787977
106. Tuo J., Bojanowski C. M., Zhou M., Shen D., Ross R. J., Rosenberg K. L., Cameron D. J., Yin C., Kowalak J. A., Zhuang Z., Zhang K., Chan C., Murine Ccl2/Cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Investigative Ophthalmology and Visual Science 2007 48 8 3827 3836 10.1167/iovs.07-0051 2-s2.0-34648846532
107. Charo I. F., Taubman M. B., Chemokines in the pathogenesis of vascular disease. Circulation Research 2004 95 9 858 866 10.1161/01.RES.0000146672.10582.17 2-s2.0-7244242357
108. Killingsworth M. C., Sarks J. P., Sarks S. H., Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 1990 4 4 613 621 10.1038/eye.1990.86 2-s2.0-0025086052
109. Penfold P. L., Killingsworth M. C., Sarks S. H., Senile macular degeneration: the involvement of immunocompetent cells. Graefe's Archive for Clinical and Experimental Ophthalmology 1985 223 2 69 76 10.1007/BF02150948 2-s2.0-0021846648
110. Penfold P. L., Provis J. M., Billson F. A., Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefe's Archive for Clinical and Experimental Ophthalmology 1987 225 1 70 76 2-s2.0-0022871473
111. Penfold P., Killingsworth M., Sarks S., An ultrastructural study of the role of leucocytes and fibroblasts in the breakdown of Bruch's membrane. Australian Journal of Ophthalmology 1984 12 1 23 31 10.1111/j.1442-9071.1984.tb01120.x 2-s2.0-0021187070
112. Lopez P. F., Grossniklaus H. E., Lambert H. M., Aaberg T. M., Capone A. Jr., Sternberg P. Jr., L'Hernault N., Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. The American Journal of Ophthalmology 1991 112 6 647 656 2-s2.0-0026048702
113. Skeie J. M., Mullins R. F., Macrophages in neovascular age-related macular degeneration: friends or foes? Eye 2009 23 4 747 755 10.1038/eye.2008.206 2-s2.0-65349167290
114. Forrester J. V., Macrophages eyed in macular degeneration. Nature Medicine 2003 9 11 1350 1351 10.1038/nm1103-1350 2-s2.0-0344845201
115. Mocellin S., Marincola F., Rossi C. R., Nitti D., Lise M., The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine and Growth Factor Reviews 2004 15 1 61 76 10.1016/j.cytogfr.2003.11.001 2-s2.0-1642554780
116. Grossniklaus H. E., Ling J. X., Wallace T. M., Dithmar S., Lawson D. H., Cohen C., Elner V. M., Elner S. G., Sternberg P. Jr., Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Molecular Vision 2002 8 119 126 2-s2.0-0036978519